Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Applied to Postoperative Intrauterine
NACompletedINTERVENTIONAL
Enrollment
192
Participants
Timeline
Start Date
February 27, 2017
Primary Completion Date
August 29, 2018
Study Completion Date
August 29, 2018
Conditions
Postoperative Adhesion of Uterus
Interventions
DEVICE
ABT13107
Dose: 3mL, maximum 10mL
DEVICE
Hyalobarrier
Dose: 10mL
Trial Locations (1)
Unknown
Asan Medical Center, Seoul
All Listed Sponsors
lead
Medy-Tox
INDUSTRY
NCT04007211 - Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Applied to Postoperative Intrauterine | Biotech Hunter | Biotech Hunter